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Abstract
Recent studies have shown that orexins play a critical role in the regulation of sleep/wake states, feeding behaviour, and
reward processes. The exocrine and endocrine pancreas are involved in the regulation of food metabolism and energy
balance. This function is deranged in diabetes mellitus. This study examined the pattern of distribution of orexin-1 receptor
(OX1R) in the endocrine cells of the pancreas of normal and diabetic Wistar (a model of type 1 diabetes), Goto-Kakizaki (GK, a
model of type 2 diabetes) rats and in orexin-deficient (OX
2/2) and wild type mice. Diabetes mellitus (DM) was induced in
Wistar rats and mice by streptozotocin (STZ). At different time points (12 h, 24 h, 4 weeks, 8 months and 15 months) after
the induction of DM, pancreatic fragments of normal and diabetic rats were processed for immunohistochemistry and
Western blotting. OX1R-immunoreactive nerves were observed in the pancreas of normal and diabetic Wistar rats. OX1R was
also discernible in the pancreatic islets of normal and diabetic Wistar and GK rats, and wild type mice. OX1R co-localized with
insulin (INS) and glucagon (GLU) in the pancreas of Wistar and GK rats. The number of OX1R-positive cells in the islets
increased markedly (p,0.0001) after the onset of DM. The increase in the number of OX1R-positive cells is associated with a
high degree of co-localization with GLU. The number of GLU- positive cells expressing OX1R was significantly (p,0.0001)
higher after the onset of DM. The tissue level of OX1R protein increased with the duration of DM especially in type 1
diabetes where it co-localized with cleaved caspase 3 in islet cells. In comparison to STZ-treated wild type mice, STZ-treated
OX
2/2 animals exhibited reduced hyperglycemia and handled glucose more efficiently in glucose tolerance test. The
findings suggest an important role for the OX-OX1R pathway in STZ-induced experimental diabetes.
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Introduction
Recent studies have shown that orexins A and B play a critical
role in the regulation of sleep/wake states, feeding behaviour, and
reward processes [1,2]. They also participate in the regulation of
food intake in a dose-dependent fashion [3,4,5] and consequently
of energy balance [6]. Orexins are related to hypocretins and
were first described by Sakurai et al. [7]. Orexins have been
demonstrated in the lateral hypothalamic region, an area of the
brain closely associated with the regulation of behaviour [8]. A
strong indication of the role of orexin-positive neurons in feeding is
that genetic ablation of orexigenic neurons results in narcolepsy,
hyperphagia and obesity [9]. Orexin-1 receptor (OX1R) was the
first of the two orexin receptors to be discovered and binds orexin-A
with a much higher affinity compared to orexin B. The human
OX1R protein consists of 425 amino acids and seven putative
transmembrane helices [10]. OX2R consists of 444 amino acids and
has equal affinities for both orexin A and B ligands. OX2R shares
about 64% amino acid identity with OX1R [1]. In addition, OX1R
is more selective for orexin A [11,12] and usually coupled to the Gq
subclass of G proteins while OX2R can couple to either Gq and/or
Gi/o subset of G proteins [1]. The binding of OX1R and OX2Rt o
either orexin A or B causes intracellular influx of Ca
2+ resulting in
increased concentration of intracellular Ca
2+ [11].
OX1R and OX2R are present in the lateral hypothalamic area
(LHA), which is rich in orexin-positive nerves [13]. In the
hypothalamic region, OX1R mRNA is located mainly in the
dorsomedial area of the ventromedial hypothalamic nucleus
(VMH) and the anterior hypothalamic territory, whereas, OX2R
mRNA is observed in several hypothalamic nuclei including the
arcuate nucleus, posteroventricular nucleus, LHA, and tubero-
mammilary bodies [13]. The localization of orexin receptors to
these hypothalamic nuclei supports the purported function of
orexins on the regulation of feeding, since food intake and appetite
are regulated by these cortical regions (VMH, LHA, arcuate
nucleus). The role of VMH in the regulation of food intake is
very strong because the selective ablation of VMH results in
obesity [12,14]. Moreover, expression of OX1R mRNA has been
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hippocampus, locus coeruleus and raphe nuclei [13]. The
localization of OX1R mRNA in these cortical regions, which
has large quantities of adrenergic and serotonergic neurotrans-
mitters suggests that orexins may also play an important role in the
regulation of serotonergic as well as adrenergic systems. OX2Ri s
also expressed in the amygdala [13] a brain region that is strongly
associated with memory and emotion. OX1R has also been shown
in the spinal cord and sensory ganglion in the mouse [15].
The expression of orexin receptor mRNA is not confined only
to the central nervous system. Low OX1R mRNA expression has
been observed in the adrenal gland of the rat [16] and human
[17], stomach and intestinal circular muscle as well as mucosal and
myenteric nerve plexuses in rat [18] and in the bovine
urethroprostatic complex [19]. In contrast, OX2R mRNA
expression is localized to neuroendocrine cells of the alimentary
mucosa [20]. The pancreas has been shown to particularly express
OX1R mRNA [12]. Previous studies from our laboratory have
shown that OX1R is present in nerves and endocrine cells of the
pancreas of normal and diabetic rats [21].
Since diabetes mellitus is associated with a dysfunction of
glucose metabolism, the aim of this study was to examine whether
diabetes mellitus will induce changes in the pattern of distribution
of OX1R in the endocrine cells of Wistar and GK rats and mice
pancreas.
Materials and Methods
Experimental Animals
a). Streptozotocin-induced diabetes mellitus (a model of
type 1 diabetes). Male Wistar rats (12-week old) obtained from
United Arab Emirates University breeding colony, weighing
approximately 250 g were used in this study. The study was
approved by the Animal Ethics Research Committee at the
Faculty of Medicine & Health Sciences. The guidelines set by this
committee for animal husbandry and welfare, based on Helsinki
Declaration of 2006 was followed. The rats were divided into two
groups, streptozotocin (STZ)-induced diabetics and age-matched
controls. Diabetes was induced by a single intraperitoneal injection
of STZ (Sigma, Poole, UK) at 60 mg kg
21 (200 mg kg
21 for mice)
prepared in 5 mM citrate buffer pH 4.50 [22]. The animals were
kept in plastic cages and maintained on standard laboratory
animal diet with food and water ad libitum. One-Touch II H
Glucometer (LifeScan, Johnson and Johnson, Milpitas, CA, USA)
was used to measure the blood glucose for each individual animal.
The animals were considered diabetic if the random blood glucose
levels were $300 mg dl
21. At different time points (12 h, 24 h, 4
weeks, 8 months and 15 months) after the induction of DM, all of
the animals from both groups were sacrificed under chloral
hydrate general anesthesia (7% chloral hydrate 6-ml kg
21 of body
weight, given intraperitoneally). The tail end of the pancreas was
rapidly removed, fixed in Zamboni’s solution [23] and processed
for immunohistochemistry and immunofluorescence. Pancreatic
tissue samples were also expeditiously removed, frozen and set
aside for Western blot analysis. Orexin-deficient and C57BL/6
wild type mice were treated with STZ and processed in a similar
way after 1 week.
b). Goto-Kakizaki rats (a model of type 2 diabetes
mellitus). The colony of GK rats were obtained from
Taconic Inc. (Ejby, Denmark) and bred in our laboratory. GK
rats are non-obese and exhibits similar metabolic, hormonal and
vascular disorders to the human disease [24]. They are known to
have relatively mild diabetes until the pancreas is exhausted [24].
Six GK rats were used for the experiment.
c). Orexin deficient (OX
2/2) mice. Founder orexin
deficient (OX
2/2) mice were on a C57BL/6J-129/SvEV
background, and their offspring were backcrossed with C57BL/6J
micefor6–8generations[25].OX
2/2micewerekindly donated by
Dr. Thomas Scammell, Harvard University Medical School,
Boston, USA. Five OX
2/2 and 6 wild type mice were used for
the experiment.
Immunohistochemistry
Pancreatic tissue fragments from six normal and diabetic rats
from eachgroup (timepoint), weretrimmed free of adherent fat and
connective tissue and cut into small pieces (2 mm
3) and fixed
overnight in Zamboni’s solution [23], dehydrated and embedded in
paraffin wax according to a previously described method [22].
Sections of 6 mm thickness were cut on a microtome (Shandon
AS325, Pittsburg, PA, USA) and processed for immunohistochem-
istry according the method described by Adeghate et al. [21,22].
Briefly, after 30 min incubation in the blocking reagent the
appropriate dilution of primary antibodies (OX1R) and negative
control (Phosphate buffered solution: PBS) reagents were applied.
The sections were incubated in primary antibodies for 24 h at 4uC.
The slides were then washed and incubated for 30 min with
prediluted biotinylated anti-rabbit IgG. After washing in PBS the
sections were incubated in streptavidin peroxidase conjugate for
45 min. After a final wash in PBS, the peroxidase activity was
revealed by incubating the specimens in 3, 3-diaminobenzidine
tetrahydrochloride containing 0.03% hydrogen peroxide in PBS.
The slides were later washed, and counter-stained with haematox-
ylin for 30 s and mounted in Cytoseal 60 (Stephens Scientific,
Riverdale, USA). Slides were examined under Zeiss Axiophot
microscope and immunopositive islets cells and nerves of the tissue
sections were photographed. The antiserum to OX1R was
purchased from Santa Cruz (CA, USA) and was used at a dilution
of 1:1000. No specific immunostaining was observed in pancreatic
tissue when primary antiserum was omitted.
Morphometric analysis of OX1R-, insulin-, glucagon- and
caspase-immunoreactive cells in pancreatic endocrine
cells
In order to determine whether diabetes mellitus influences the
number and pattern of distribution of OX1R-, insulin-, glucagon-
and caspase-immunoreactive cells, the total number of cells in the
islets of Langerhans of normal and diabetic rats was counted using
AxiovisionH Image Analysis System (Zeiss, Gottingen, Germany)
attached to a fluorescent microscope. Thereafter, OX1R-immu-
noreactive cells and those co-localized with either insulin (INS) or
glucagon (GLU) in a given islet were also counted. The number of
OX1R-immunoreactive cells or those that co-localized with INS or
GLU was divided by the total number of cells to give the
percentage distribution. Isolated OX1R-postive cells or those co-
localized with INS- or GLU-positive cells were counted in visible
sections at X40 magnification. A total of 10 random islets were
taken from a total of 6 slides for each group. The values obtained
from sections of the islets of Langerhans of normal rat were
compared with those of diabetic rat.
Immunofluorescence
a). Co-localization of OX1R with pancreatic hormones in
islet cells. The co-localization of OX1R with either INS or
GLU in pancreatic islets of normal and diabetic rats was
performed with double-labeled immunofluorescence method as
described by Adeghate and Ponery [26]. Briefly, 6 mm thick
sections of normal and diabetic rat pancreas were deparaffinized
Orexin Receptors in Islets
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8587with xylene, and rehydrated with descending concentrations of
ethanol. The sections were treated with a blocking agent for
30 min at room temperature after washing in PBS. The sections
were later incubated with sheep OX1R goat polyclonal antibody
(1:1000) overnight at 4uC. The same sections were later incubated
overnight at 4uC with either INS or GLU antibody (Prediluted
from Dako, Denmark) after labeling with TRITC (1: 100). Sites
of immunoreaction were detected using anti-guinea pig FITC
(1: 100) for INS and anti-rabbit FITC for GLU. The sections were
mounted in ImmunomountH (Shandon, Pittsburgh, PA, USA) and
viewed with a Zeiss fluorescent microscope.
b). Co-localization of OX1R with Caspase 3 in islet
cells. Some studies [27,28,29] have linked OX1R with the
apoptotic pathway, where orexin stimulates OX1R to induce large
scale cell death in cancer cell lines. In order to determine whether
there is a link between OX1R and the apoptotic pathway in
pancreatic islet cells, a double staining immunofluorescence method
described above was used to identify OX1R and cleaved caspase 3
(pre-diluted; an apoptotic marker; Cell Signaling Technology, Inc.,
Beverly, MA, USA; Cat # 8120) simultaneously in pancreatic islets
of OX
2/2 and C57BL/6 mice.
Western blotting
a). The time course for the development of increased
OX1R. Pancreatic tissue samples from different experimental
time points were homogenized in 1 ml of lysis buffer [1% NP-40,
25 mM Tris pH 7.4, 0.1 mM EDTA, 1 mM DTT, protease
inhibitor cocktail set III (Calbiochem, San Diego, CA, USA) on
ice. After incubating the homogenates on ice for 15 min, samples
were centrifuged at 13000 rpm for 15 min at 4uC. Clarified cell
lysates were collected and total protein concentrations were
measured by the Bradford method (Bio-Rad protein assay, Bio-
Rad laboratories, Munich, Germany). The lysates (200 mg
protein/lane) were resolved on a 10% SDS-PAGE, transferred
to a PVDF membrane (Bio-Rad), and blocked with 5% nonfat
milk powder in TBS containing 0.01% Tween 20 at room
temperature for 1 h. Membranes were incubated with OX1R
antibody (1:1000, goat-anti-rat orexin R-1, Santa Cruz
Biotechnology, USA) overnight at 4uC, washed, and incubated
with horse radish peroxidase-conjugated anti-goat IgG secondary
antibody (Sigma, UK) for 1.5 h at room temperature. Blots were
washed and developed using SuperSignal substrate (Pierce,
Rockford, IL, USA).
b). OX1R and its relation to apoptosis. In a bid to
examine a possible link between OX1R and apoptosis, pancreatic
tissue samples from control OX
2/2 and C57BL/6 and STZ-
treated OX
2/2 and C57BL/6 mice were homogenized and
processed for Western blotting as described above. Membranes
were incubated overnight at 4uC with either anti orexin R-1 or
anti b-actin antibodies (1:1000, Santa Cruz Biotechnology, USA),
or anti-PARP antibody (1:1000, R&D Systems Inc., Minneapolis,
USA). The blots were further processed as described above and
developed using SuperSignal substrate.
Glucose tolerance test
In order to investigate the ability of orexin knockout (OX
2/2)
and wild type (C57BL/6) mice to handle glucose challenge,
control OX
2/2 and C57BL/6 and STZ-treated OX
2/2 and
C57BL/6 mice were fasted overnight (12 h) prior to the test. Each
mouse was given a glucose load of 3 g/kg body weight intra-
peritoneally, according to Zhang and Tan [30]. Blood samples
were collected from the tail vein at time 0 (prior to the glucose
load), 30, 60 and 180 minutes after the glucose load.
Statistical analysis
All values were expressed as mean6standard error of the mean
(SEM). Statistical significance was assessed using Student’s t-test.
Values with p,0.05 were accepted as significant.
Results
OX1R in nerves innervating the pancreas
Peripheral nerves located in the interlobular, perivascular, and
periductal regions of the pancreas of both normal and diabetic rats
contain OX1R( F i g .1 a ,b ,c ,d ) .M o r e o v e r ,i n t r i n s i c ,n e u r o n a lg a n g l i o n
cells of the pancreas of normal rat also expressed OX1R( F i g .1 c ) .
Co-localization of OX1R with insulin (INS) and glucagon
(GLU)
Figure 2 shows the expression of OX1R and the peptide hormones,
INS and GLU in the islet cells of the pancreas of normal and diabetic
Wistar and GK rats. Islet cells expressing OX1R were discernible in
both the peripheral and central regions of the islets of Langerhans in
normal Wistar rats (Fig. 2a, 2d). The pancreas of Wistar diabetic (a
model of type 1 diabetes) and GK (a model of type 2 diabetes) rats
also contained OX1R. OX1R immunoreactive cells were located in
the peripheral as well as in the central parts of the islets. The number
of OX1R-immunoreactive cells in the pancreatic islet of normal and
diabetic rats was 21.2464.5 and 62.8610.5, respectively.
Figure 2a showed INS and OX1R-positive cells in pancreatic
islets of normal rats. OX1R was expressed in many INS-positive
cells in the pancreas of normal rat. However, in diabetic rat
pancreas (Fig. 2b), only a few cells contained insulin. Few of the
surviving INS-positive cells expressed OX1R as well. In a similar
fashion, INS-producing cells in the pancreas of GK rats also
contained OX1R (Fig. 2c).
In contrast to the small degree of co-localization observed
between OX1R and INS pancreatic islet cells of diabetic Wistar
rats, a much larger subset of GLU-positive cells expressed OX1R
in diabetic Wistar rats (Fig. 2e) compared to normal pancreas
(Fig. 2d). The number of GLU-immunoreactive cells increased
significantly after the onset of diabetes. This increase was
associated with a concomitant increase in the number of cells
expressing OX1R (Fig. 2e). GLU-immunoreactive cells expressing
OX1R were observed in both the peripheral and central portions
of the islet after the onset of diabetes. The expression of OX1Ri n
GLU-positive cells was significantly higher in diabetic rats
compared to normal. The degree of co-localization of between
GLU and OX1R in GK rats (Fig. 2f) was not significantly different
from that observed in Wistar normal (Figs 2d).
Morphometric analysis of OX1R immunoreactive cells
co-localized with either insulin (INS) or glucagon (GLU) in
Wistar rats
OX1R co-localized with INS in a large number of INS-
producing beta cells in the pancreas of normal Wistar rat. The
number of OX1R-containing cells that contain INS decreased
significantly (p,0.001) after the onset of diabetes. Although some
OX1R-positive cells also contained GLU, the percentage distri-
bution of GLU-immunoreactive cells that co-localized with OX1R
rose significantly (p,0.0001) after the onset of diabetes when
compared to normal (Fig. 3).
OX1R immunoreactive cells in the islet of Goto Kakizaki
rats
The Goto-Kakizaki (GK) rat is a model of type 2 diabetes with
similar metabolic disorders compared to human diabetes. GK rats
Orexin Receptors in Islets
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Immunohistochemistry was performed to examine whether the
pattern of distribution of OX1R is similar in the pancreatic islets of
GK compared to Wistar rats. The pancreatic islets of GK rats
contain numerous OX1R-imunoreactive cells similar to that
observed in the islet of diabetic Wistar rats (Fig. 4).
Time course of diabetes-induced changes in OX1R
expression
The expression of OX1R in the pancreas of diabetic rats was
investigated at different time points after the induction of DM.
The expression of OX1R increased with the duration of DM from
pale staining 12–24 h after the onset of DM to intense expression
8–15 months after the induction of DM (Fig. 5).
Semi-quantitative analysis of OX1R protein expression in
pancreatic islets of normal and diabetic Wistar rats
Western blot analysis of pancreas segments from normal and
diabetic rats was performed to quantify the tissue content of OX1R.
The expression of OX1R protein was highest in the pancreas of rats
with long-term DM, namely 8 and 15 months and low in the
pancreas of rats with acute to short-term (12–24 h) DM (Fig. 6).
OX1R and markers of apoptosis
a). Co-localization of OX1R and Caspase 3. In order to
examine a possible link between OX1R and cleaved caspase 3
in pancreatic islet of OX
2/2 and C57BL/6, we used immu-
nofluorescence method to simultaneously localize OX1R and
cleaved caspase 3. Cleaved caspase 3-positive cells were located in
the peripheral region of pancreatic islets in OX
2/2, C57BL/6
mice and normal Wistar rats (Figs. 7a–c). The pancreatic islet of
C57BL/6 mice contained a significantly larger number of OX1R-
immunoreactive cells compared to the mutant type. The ratio of
OX1R-positive cells in the pancreas of the wild type to that of
OX
2/2 mice was 20:1. In addition, the number of cleaved caspase
3-positive cells was significantly lower in OX
2/2 mice when
compared to that of wild type. The ratio of cleaved caspase
3-positive cells in the islets of Langerhans of the wild type to that of
orexin knockout mice was 6:1 (Fig. 7).
Cleaved caspase 3-positive cells were relatively high in the
islets of normal Wistar rats compared to wild type and OX
2/2
mice. However, the number of OX1R- and cleaved caspase
3-immunoreactive cells increased significantly (p,0.001) after the
onset of STZ-induced diabetes. The degree of co-localization of
OX1R with cleaved caspase 3 was more than 90%. This values
was significantly higher in Wistar diabetic rats than those obtained
in orexin deficient or wild type mice (Fig. 8).
b). Western blot analysis of OX1R and the apoptotic
marker PARP {poly (ADP-ribose) polymerase} in pancreatic
islets of control or STZ-treated OX
2/2 and C57BL/6
mice. To further elucidate the link between OX1R and
apoptosis, we used Western blotting technique to semi-quantify
pancreatic tissue levels of OX1R protein and the apoptotic marker
PARP polymerase, a DNA repair enzyme which is targeted by
active caspase 3 during apoptosis.
Figure 1. Immunolocalization of OX1R in intrapancreatic nerves. Light micrographs showing OX1R-immunoreactive nerve fibers (arrow) in
the pancreas of normal (a), and diabetic (b, d) rats. OX1R expression is equally present in the nerve fibers of both normal and diabetic (4 weeks after
the onset of diabetes) rats. Ganglion cells (arrow) of normal pancreas (c) expressed OX1R. Magnification: 6400.
doi:10.1371/journal.pone.0008587.g001
Orexin Receptors in Islets
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mice but was upregulated in the pancreas of OX
2/2 mice after
the onset of STZ-induced diabetes. In contrast, the expression of
PARP, an indication of proteolysis by active caspase 3, was robust
in the pancreas of C57BL/6 mice but decreased markedly in
OX
2/2 mice (Fig. 9).
Glucose handling in control or STZ-treated OX
2/2 and
C57BL/6 mice
We observed that OX1R co-localizes with INS in pancreatic
beta cell and it is up-regulated in diabetes. Control OX
2/2 and
C57BL/6 and STZ-treated OX
2/2 and C57BL/6 mice were
challenged with intra-peritoneal glucose load to examine whether
the orexin/OX1R system has a role to play in glucose metabolism.
Blood glucose levels of control OX
2/2 and C57BL/6 mice were
similar at time 0, 30, 60, 180 min. In contrast, blood glucose level
of STZ-induced diabetic OX
2/2 mice was slightly but not
significantly lower than that of diabetic C57BL/6 mice at 0 min.
Diabetic OX
2/2 mice displayed a significantly lower blood
glucose levels compared to those of diabetic wild type at 60 and
180 min after glucose challenge. The efficacy of glucose handling
by STZ-treated OX
2/2 mice approached that of control OX
2/2
and C57BL/6 mice (Fig. 10).
Discussion
OX1R in pancreatic nerves of normal and diabetic rats
The observations of this study showed that OX1R is present in
the intrinsic neuronal ganglion and nerve fibers innervating the
pancreas of both normal and diabetic Wistar rats. There was no
difference between the pattern of distribution of OX1R-postive
Figure 2. Co-localization of orexin-1 receptor (OX1R) with either insulin (INS) or glucagon (GLU) in pancreatic islets.
Immunofluorescence images showing orexin-1 receptor (OX1R)-immunoreactive cells (red) with either, (a) INS (green) or (d) GLU (green) in the
pancreatic islet of normal rats. Many cells (orange-yellow) contain both OX1R and INS in the pancreas of normal Wistar rats (a). Only few cells contain
both OX1R and GLU in the endocrine pancreas of normal Wistar rats (d). In diabetic (4 weeks after the onset of diabetes) rats, the number of INS cells
decreased (b). However, some surviving INS-positive cells also contained OX1R (orange-yellow) (b). OX1R also co-localized (orange-yellow) with INS in
the pancreatic islets of GK rats (c). A large number of GLU-positive cells expressed OX1R after the onset of streptozotocin-induced diabetes (e). There
was little to no co-localization of GLU and OX1R in the islet of GK rats (f). INS=insulin, GLU=glucagon; GK=Goto Kakizaki. Magnification: 6200
doi:10.1371/journal.pone.0008587.g002
Figure 3. Mean number of pancreatic OX1R-immunoreactive
cells containing either insulin or glucagon. Histograms of the
mean of the distribution of OX1R-immunoreactive cells containing
either INS or GLU in normal and diabetic (4 weeks after the onset of
diabetes) rat pancreas. *(p,0.01: OX1R/INS in control versus diabetic);
**(p,0.0001: OX1R/GLU in control versus diabetic). INS=insulin,
GLU=glucagon. (10 islets from 6 animals/group).
doi:10.1371/journal.pone.0008587.g003
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of OX1R-immunopositive nerves confirms the result of previous
studies from our laboratory [21]. OX1R expression has been
reported in the submucosal and myenteric plexuses of the guinea-
pig and rat ileum [12]. Orexins/orexin receptors have also been
implicated in several functions in the alimentary tract. These
biological functions include local neuronal excitations, gut
motility, blood flow and absorption and secretion by alimentary
epithelium [10]. OX1R-positive nerves may release orexins to act
as a conduit in the implementation of various biological functions
in the pancreas and in other organs. Previous studies have shown
that Orexin-A stimulates pancreatic fluid and protein release [31].
This orexin-induced increase in pancreatic exocrine secretion is
mediated through the vagus, the cranial nerve that innervates the
pancreas. This indicates that branches of the vagus supplying the
pancreas and other abdominal organs may contain OX1R.
Figure 4. Comparison of OX1R-immunoreactivity in the endocrine pancreas of Wistar and GK rats. Light micrographs showing
OX1R-immunoreactive cells in the pancreatic islet of normal Wistar (a) and Goto Kakizaki (b) rats. Note that the islet cells of Goto Kakizaki stains more
intensely for OX1R compared to Wistar. Magnification: 6200.
doi:10.1371/journal.pone.0008587.g004
Figure 5. Localization of OX1R in the pancreatic islets of Wistar rats with acute, short- and long-term diabetes mellitus. Light
micrographs showing OX1R-immunoreactive cells in the pancreatic islet of Wistar 12 h (a); 24 h (b); 8 months (c) and 15 months (d) after the onset of
diabetes. Note the large number of islet cells containing OX1R in long-term diabetes (c) and (d). Magnification: 6200.
doi:10.1371/journal.pone.0008587.g005
Orexin Receptors in Islets
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The present study and those reported previously [21] from our
laboratory confirm that the number of OX1R-positive cells in the
islet of Langerhans increased significantly in diabetic rats
compared to normal. The reason(s) for the increase in the number
of OX1R-immunoreactive cells in the islet of diabetic rats is not
clear. A possible reason could be the low intracellular glucose level
observed in type 1 DM. The loss of insulin in diabetic rats means
less glucose will be transported into most cells, thus up-regulation
OX1R expression. Several reports have shown that orexin-positive
neurons [32] as well as OX1R and OX2R [33] are activated
during fasting. The number of OX1R-positive cells in both the
central and peripheral regions of the islets of Langerhans increased
after the onset of diabetes. OX1R-positive cells are not the only
cells that increase after the onset of diabetes, for example the
number of GLU-immunoreactive cells increased significantly in
diabetes [22]. It is worth noting that OX1R was observed only in
pancreatic islet cells as well as in nerves. OX1R expression was not
seen in the parenchymal cells of the exocrine pancreas. It is not
clear why OX1R is not observed in the parenchymal cells of the
exocrine pancreas. The fact that OX1R expression was observed
in both neurons and pancreatic endocrine cells of the islet of
Langerhans is not surprising because there is similarity in the
origin of neurons and islet cells. In fact, some studies have shown
that the endocrine pancreas mature along a pathway similar to
that of neuron [34]. OX1R may therefore be confined to cells of
neuronal origin.
It was interesting to observe OX1R expression in the islet of GK
rats, an animal model of type 2 diabetes. The expression of OX1R
in the pancreas of GK rats was higher than those in the pancreas
of normal Wistar rat but similar to that seen in the pancreas of
diabetic Wistar rats. This observation probably points to a
common denominator that induces increased OX1R expression
in the pancreatic islet of type 1 diabetic rats.
Co-localization of OX1R with INS- and GLU in the
pancreatic islets of normal and diabetic Wistar and GK
rats
Several pancreatic beta cells of normal Wistar rats contained
OX1R. In diabetic Wistar rat pancreas, the number of INS-
positive cells expressing OX1R decreased with a concomitant
increase in the number of OX1R-positive cells. It is well known
that the number of INS-positive cells is decreased in diabetes [35].
The co-localization of OX1R INS in the pancreas of normal
Wistar rats indicates a functional role for OX1R in the regulation
of insulin metabolism and consequently that of glucose. GLU-
immunoreactive cells expressed OX1R in the islets of normal and
diabetic rats. It is not clear why the number of INS-producing
pancreatic beta cell containing OX1R decreased after the onset of
diabetes even though there is an increase in the number of OX1R-
positive cells. A possible reason could be an existence and
proliferation of a subpopulation of pancreatic beta cell than
contain only OX1R. Another reason could be the absence of INS
in old and newly formed OX1R-positive cells.
The co-localization of OX1R and INS is further confirmed by
the fact that a similar pattern was seen in the islet of GK rats, an
animal model of type 2 diabetes, where hyperglycaemia is much
milder. All of these support a functional role of OX1R and the
orexinergic system in the regulation of carbohydrate metabolism.
This is the first report on the co-localisation of INS and GLU
and OX1R. The number of GLU-positive cells expressing OX1R
increased significantly after the onset of type 1 diabetes. Although,
OX1R is present in the pancreatic islets of GK rats, a model of
type 2 diabetes, the degree of co-localization with GLU was
minimal compared to that STZ-induced diabetic rat (a model of
type 1 diabetes). This may be due to the fact that the
hyperglycaemia is much milder in GK compared to STZ-treated
Wistar rats. The co-localization of OX1R with INS and GLU
suggests a pivotal role for INS and GLU in the biological actions of
orexins. Moreover, orexins evoked the release of INS [36] and
GLU [37] from normal pancreatic islets. This orexin-induced INS
release may be due to GLU action. GLU as we know, stimulates
INS secretion [38].
OX1R was also upregulated in PP-positive islets cells after the
onset of diabetes (result not shown). The reason for the increase in
the expression of OX1R in pancreatic polypeptide (PP)-immuno-
reactive cells is unknown. Since OX1R is present in PP-positive
cells, orexin may stimulate the release of PP, which may in turn
enhance appetite. It has been shown that centrally administered
PP elicits food intake via NPY receptors [39]. The hypothetical
relationship between pancreatic hormones, orexins, obesity,
energy utilization, wakefulness/arousal is depicted in figure 11.
Time course of diabetes-induced changes in OX1R
expression and quantitative analysis
This study showed a larger increase in OX1R expression in the
pancreatic islets of rats with long-term DM compared to those
with short-term diabetes. The reason for this observation is not
Figure 6. Expression of orexin-1 receptor (OX1R) protein in the
pancreatic islets of Wistar rats with acute, short- and long-term
diabetes mellitus. Western blot analysis of OX1R protein expression in
the pancreas of normal and diabetic rats at different time points of
diabetes. Note that the tissue level of OX1R protein was significantly
(p , 0.0001, Students’t-test) higher in the pancreas of long-term (8 and
15 months) rats compared to that of rats with acute and short-term
diabetes mellitus (n=6). 1: Control 8 months; 2: Diabetic 8 months;
3: Control 15 months; 4: Diabetic 15 months 5, 6 and 7: Diabetic 12 h;
9 Diabetic 24 h.
doi:10.1371/journal.pone.0008587.g006
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pancreatic tissue due to persistent hyperglycaemia and other
inductors of oxidative stress. Oxidative stress is a major cause of
late complications of DM and may be more pronounced in the
pancreas of rats with long and established DM [40]. This may in
turn contribute to the high tissue level of OX1R protein observed
in the pancreas of rats with long-term diabetes.
OX1R and markers of apoptosis
Cleaved caspase 3, indicative of an activated enzyme, is a
critical step in the apoptosis pathway. Expression of active caspase
3 was discernible in the cells of the peripheral regions of the islets
of OX
2/2 and C57BL/6 mice and normal Wistar rats. The
number of caspase 3-positive islet cells was significantly fewer in
OX
2/2 mice compared to C57BL/6 mice. It is worth noting that
OX
2/2 mice have significantly fewer OX1R compared to wild
type. It does appear that the number of OX1R-positive cells is
directly proportional to that of caspase 3. The use of OX
2/2 mice
shows that the fewer the number of OX1R-immunoreactive cells,
the lower the number of caspase 3-positive cells becomes.
In contrast, the number of OX1R- and caspase 3-postive cells
increased significantly after the onset of STZ-induced diabetes in
Wistar rats. A significant number of pancreatic islet cells of this
animal model contain both OX1R- and caspase 3. This shows a
link, albeit in diabetic rat pancreas, between orexin and apoptotic
pathways.
A link between OX1R and apoptosis has been described by
Voisin et al, [27], Laburthe et al [28] and El Firar et al [29]. They
showed that orexins induce apoptosis via OX1R in cancer cell
lines.
OX1R and the apoptotic marker, PARP in pancreatic islets
of control or STZ-treated OX
2/2 and C57BL/6 mice
Western blot technique showed the expression of PARP in the
pancreas of both orexin knockout and wild type mice. The tissue
level of PARP decreased after the induction of experimental
diabetes in orexin-deficient mice. It is not clear why PARP was
well expressed in the pancreas of normal wild type and knockout
mice at least when they were not subjected to any toxins that could
possibly induce oxidative stress and therefore apoptosis.
The pancreas of orexin knockout mice contained a small
quantity of OX1R compared to the pancreas of the wild type.
However, the tissue level OX1R increased after the onset of
diabetes in the mutant, but not in control mice. The reason for the
increase in not known, but it may be due to the modulation of the
orexinergic system by STZ, especially in the absence of orexin in
Figure 7. Co-localization of orexin-1 receptor (OX1R) with cleaved caspase 3 in pancreatic islet cells of wild type (C57BL/6) mice,
orexin knockout mice, and normal and diabetic Wistar rats. Immunofluorescence images showing co-localization of orexin-1 receptor (OX1R)
(green) with cleaved caspase 3 (red) in pancreatic islet cells of C57BL/6 mice (a), orexin knockout mice (b), normal Wistar (c) and diabetic Wistar (d)
rats. OX1R-positive cells are located in the peripheral region of the islets of C57BL/6 and orexin knockout mice and normal Wistar rats. However, in
diabetic Wistar rats (d), there is a high degree of co-localization (orange-yellow) between OX1R and caspase 3 in many pancreatic islet cells. It is worth
noting that the number of OX1R (green) and cleaved caspase 3 (red) immunoreactive cells are significantly reduced in orexin knockout mice.
Magnification: 6200.
doi:10.1371/journal.pone.0008587.g007
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onset of diabetes in the mutant mice was accompanied by a
decrease in the expression of PARP when compared to control,
non-diabetic mutant mice and control as well as diabetic wild type.
The reason for this inverse relationship is unclear but it may be
due to the absence of orexin, a major trigger of apoptosis.
Figure 8. Distribution of OX1R-, cleaved caspase 3- and OX1R/
cleaved caspase 3- immunopositive cells in pancreatic islet of
C57BL/6 mice, orexin knockout mice, normal and diabetic
Wistar rats. Histograms of the pattern of distribution of OX1R-positive
(green), cleaved caspase 3-immunoreactive cells (red) and cells
containing both OX1R and cleaved caspase 3- in the pancreas of in
pancreatic islet cells of C57BL/6 mice, orexin knockout mice, normal
Wistar and diabetic Wistar rats. Note the direct correlation between the
number of OX1R-positive cells and that of cleaved caspase 3. The
number of cells containing both OX1R cleaved caspase 3 is significantly
elevated in streptozotocin-induced diabetic Wistar rats.
doi:10.1371/journal.pone.0008587.g008
Figure 9. Expression of OX1R protein and PARP (poly-ADP-
ribosome polymerase) in the pancreas of control or streptozot-
ocin (STZ)-treated OX
2/2 and C57BL/6 mice. Western blot analysis
ofOX1RproteinandPARP(poly-ADP-ribosomepolymerase)expressionin
the pancreas of control or STZ-treated OX
2/2 and C57BL/6 mice are
shown in lanes 1 and 2. Lane 1 shows that the OX1R expression was not
enhanced in the pancreas of wild type mice but was upregulated in the
pancreas of OX
2/2 mice after the onset of STZ-induced diabetes. In
contrast, the expression of PARP was robust in the pancreas of C57BL/6
mice but decreased markedly in OX
2/2 mice treated with STZ (Lane 2).
Lane 3 shows the expression of the control protein, beta actin.
doi:10.1371/journal.pone.0008587.g009
Figure 10. Glucose tolerance test in control or streptozotocin (STZ)-treated OX
2/2 and C57BL/6 mice. The graph shows blood glucose
levels in control or STZ-treated OX
2/2 and C57BL/6 mice 0, 30, 60 and 180 min after intra-peritoneal glucose challenge (3 g/kg body weight, given
intra-peritoneally). Blood glucose levels of control OX
2/2 and C57BL/6 mice were similar at time 0, 30, 60, 180 min. Note that blood glucose level of
STZ-induced diabetic OX
2/2 mice was slightly but not significantly lower than that of diabetic C57BL/6 mice at 0 min. Diabetic OX
2/2 mice displayed
a significantly (p,0.01) lower blood glucose levels compared to those of diabetic wild type at 60 and 180 min after glucose load.
doi:10.1371/journal.pone.0008587.g010
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2/2 and C57BL/6 and
STZ-treated OX
2/2 and C57BL/6 mice
We showed for the first time that STZ-induced diabetic orexin
knockout mice shows a more efficient glucose handling compared
to control OX
2/2 and C57BL/6 and STZ-treated C57BL/6
mice. Since STZ causes oxidative stress and apoptosis [40,41], it is
of great interest to observe a reduced PARP expression in the
mutant mice. It is possible that STZ induces pancreatic beta cell
apoptosis via the orexin pathway. So if orexin is missing, as in the
mutant mice, then less apoptosis will occur and more beta cell will
survive after the administration of STZ. The mutant mice injected
with STZ will therefore handle glucose more effectively as
observed in our study.
Conclusion
The number of cells expressing OX1R is increased in pancreatic
islets after the onset of diabetes. The longer the duration of
diabetes the more intense the OX1R expression becomes. OX1R-
positive islet cells co-localizes with INS and GLU in Wistar rats
and with cleaved caspase 3 after the onset of diabetes in Wistar rats
treated with STZ. The expression of OX1R and caspase 3 is
significantly lower in the pancreas of orexin knockout mice
compared to wild type and Wistar rats.
Orexin knockout mice treated with STZ have the ability to
handle glucose load more effectively that control OX
2/2 and
C57BL/6 and STZ-treated C57BL/6 mice. STZ requires the
orexinergic system to cause severe apoptosis that can consequently
lead to an overt diabetes.
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